Self Injection Device Market Size, Share, Industry Trends and Forecast to 2030

Market Size & CAGR of Self Injection Device Market in 2021

The global self-injection device market is anticipated to have a CAGR of 5.2% from 2021 to 2027. The market size is expected to reach USD 105.4 billion by 2027. The increasing prevalence of chronic diseases such as diabetes, rheumatoid arthritis, and multiple sclerosis is driving the demand for self-injection devices.

COVID-19 Impact on the Self Injection Device Market

The COVID-19 pandemic had a mixed impact on the self-injection device market. On one hand, there was an increase in demand for self-injection devices as patients preferred to self-administer their medications at home to avoid hospital visits. On the other hand, disruptions in the supply chain and manufacturing processes led to temporary delays in the market.

Self Injection Device Dynamics

The self-injection device market is driven by factors such as the increasing prevalence of chronic diseases, technological advancements in injectable drug delivery systems, and the preference for self-administration of medications. However, challenges such as stringent regulations and high costs associated with self-injection devices hinder market growth.

Segments and Related Analysis

The self-injection device market is segmented based on product type, application, and end user. The product type segment includes pen injectors, autoinjectors, needle-free injectors, and wearable injectors. The application segment covers diabetes, autoimmune diseases, cardiovascular diseases, and others. The end user segment includes hospitals, clinics, home care settings, and others.

By Region Analysis

The self-injection device market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the market in 2021 due to the high prevalence of chronic diseases and the presence of key market players. Asia Pacific is expected to witness significant growth during the forecast period due to the increasing adoption of self-injection devices in emerging economies.

Key Market Players and Competitive Landscape

Key market players in the self-injection device market include BD, Johnson & Johnson, Eli Lilly and Company, Novo Nordisk, and Pfizer. These companies are focusing on strategic collaborations, product launches, and acquisitions to enhance their market presence. The market is highly competitive with a strong emphasis on innovation and product development.

Recent Happenings in the Self Injection Device Market

- In January 2022, BD launched a new needle-free injection system for self-administration of medications. - In March 2022, Johnson & Johnson acquired a medical device company specializing in self-injection devices. - In May 2022, Novo Nordisk announced the development of a smart pen injector for diabetes management. - In July 2022, Pfizer introduced a wearable injector for the delivery of biologic drugs.